Dr. Pedro L. Del Valle completed his undergraduate work in marine biology in Colombia, a MS in environmental toxicology and a PhD in toxicology at the University of Maryland. He is a Fellow of the Academy of Toxicological Sciences (ATS). Dr. Del Valle is currently a Senior Pharmacology and Toxicology reviewer for benign hematology drug products in the Center for Drug Evaluation and Research (CDER) of the US Food and Drug Administration (FDA). He is also an Adjunct Professor at Hartwick College in the Translational Biomedical Research Management master's program. He has worked in early discovery, lead optimization and nonclinical development of small molecule pharmaceuticals and biologics with more than 20 years of experience in general toxicology, carcinogenicity, and reproductive toxicology studies and in Good Laboratory Practices (GLP) and regulatory toxicology. Dr. Del Valle is passionate about mentoring students and peers and participates in mentoring activities in the Society of Toxicology, American College of Toxicology and at work. He is a member of ACT, SOT, Society for Birth Defects Research & Prevention (BDRP), and RAPS.